Participants with higher CumTyG and CumBP values at baseline had higher mean BMI, heart rate, and hs-CRP values; higher prevalences of hypertension and diabetes; and were more likely to be taking antihypertensive, antidiabetic, and lipid-lowering medications. This evidence concerns the gene CRP and hypertensive disorder.